333 related articles for article (PubMed ID: 30939409)
1. Hypoxia alleviation-triggered enhanced photodynamic therapy in combination with IDO inhibitor for preferable cancer therapy.
Xing L; Gong JH; Wang Y; Zhu Y; Huang ZJ; Zhao J; Li F; Wang JH; Wen H; Jiang HL
Biomaterials; 2019 Jun; 206():170-182. PubMed ID: 30939409
[TBL] [Abstract][Full Text] [Related]
2. Fluorinated polymeric micelles to overcome hypoxia and enhance photodynamic cancer therapy.
Wang Q; Li JM; Yu H; Deng K; Zhou W; Wang CX; Zhang Y; Li KH; Zhuo RX; Huang SW
Biomater Sci; 2018 Oct; 6(11):3096-3107. PubMed ID: 30306153
[TBL] [Abstract][Full Text] [Related]
3. Nanoconjugates to enhance PDT-mediated cancer immunotherapy by targeting the indoleamine-2,3-dioxygenase pathway.
Yang X; Zhang W; Jiang W; Kumar A; Zhou S; Cao Z; Zhan S; Yang W; Liu R; Teng Y; Xie J
J Nanobiotechnology; 2021 Jun; 19(1):182. PubMed ID: 34127005
[TBL] [Abstract][Full Text] [Related]
4. Vacancy Engineering to Regulate Photocatalytic Activity of Polymer Photosensitizers for Amplifying Photodynamic Therapy against Hypoxic Tumors.
Bai J; Peng C; Lv W; Liu J; Hei Y; Bo X
ACS Appl Mater Interfaces; 2021 Aug; 13(33):39055-39065. PubMed ID: 34433248
[TBL] [Abstract][Full Text] [Related]
5. Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitor.
Huang Z; Wei G; Zeng Z; Huang Y; Huang L; Shen Y; Sun X; Xu C; Zhao C
Theranostics; 2019; 9(19):5542-5557. PubMed ID: 31534502
[TBL] [Abstract][Full Text] [Related]
6. Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy.
Wang M; He M; Zhang M; Xue S; Xu T; Zhao Y; Li D; Zhi F; Ding D
Biomaterials; 2023 Oct; 301():122257. PubMed ID: 37531778
[TBL] [Abstract][Full Text] [Related]
7. Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancer.
Yang G; Xu L; Xu J; Zhang R; Song G; Chao Y; Feng L; Han F; Dong Z; Li B; Liu Z
Nano Lett; 2018 Apr; 18(4):2475-2484. PubMed ID: 29565139
[TBL] [Abstract][Full Text] [Related]
8. Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy.
Guo X; Qu J; Zhu C; Li W; Luo L; Yang J; Yin X; Li Q; Du Y; Chen D; Qiu Y; Lou Y; You J
Drug Deliv; 2018 Nov; 25(1):585-599. PubMed ID: 29461122
[TBL] [Abstract][Full Text] [Related]
9. Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation.
Zhou Y; Ren X; Hou Z; Wang N; Jiang Y; Luan Y
Nanoscale Horiz; 2021 Feb; 6(2):120-131. PubMed ID: 33206735
[TBL] [Abstract][Full Text] [Related]
10. Light-responsive hyaluronic acid nanomicelles co-loaded with an IDO inhibitor focus targeted photoimmunotherapy against "immune cold" cancer.
Wu C; Xu J; Xie Z; Huang H; Li N; Wei X; Li T; Yang H; Li S; Qin X; Liu Y
Biomater Sci; 2021 Nov; 9(23):8019-8031. PubMed ID: 34718362
[TBL] [Abstract][Full Text] [Related]
11. Multi-shell structured upconversion nanocarriers that combine IDO inhibitor-induced immunotherapy with NIR-triggered photodynamic therapy for deep tumors.
Choi J; Kim SY
Biomater Sci; 2023 Jun; 11(13):4684-4699. PubMed ID: 37219321
[TBL] [Abstract][Full Text] [Related]
12. A Fluorinated BODIPY-Based Zirconium Metal-Organic Framework for
Chen X; Mendes BB; Zhuang Y; Conniot J; Mercado Argandona S; Melle F; Sousa DP; Perl D; Chivu A; Patra HK; Shepard W; Conde J; Fairen-Jimenez D
J Am Chem Soc; 2024 Jan; 146(2):1644-1656. PubMed ID: 38174960
[TBL] [Abstract][Full Text] [Related]
13. Monocytic delivery of therapeutic oxygen bubbles for dual-modality treatment of tumor hypoxia.
Huang WC; Shen MY; Chen HH; Lin SC; Chiang WH; Wu PH; Chang CW; Chiang CS; Chiu HC
J Control Release; 2015 Dec; 220(Pt B):738-50. PubMed ID: 26374945
[TBL] [Abstract][Full Text] [Related]
14. Activatable Photosensitizer for Smart Photodynamic Therapy Triggered by Reactive Oxygen Species in Tumor Cells.
Yuan B; Wang H; Xu JF; Zhang X
ACS Appl Mater Interfaces; 2020 Jun; 12(24):26982-26990. PubMed ID: 32432853
[TBL] [Abstract][Full Text] [Related]
15. An albumin-binding dimeric prodrug nanoparticle with long blood circulation and light-triggered drug release for chemo-photodynamic combination therapy against hypoxia-induced metastasis of lung cancer.
Luo R; Zhang Z; Han L; Xue Z; Zhang K; Liu F; Feng F; Xue J; Liu W; Qu W
Biomater Sci; 2021 May; 9(10):3718-3736. PubMed ID: 34008617
[TBL] [Abstract][Full Text] [Related]
16. Sensitization of Hypoxic Tumor to Photodynamic Therapy via Oxygen Self-Supply of Fluorinated Photosensitizers.
Liu Z; Xue Y; Wu M; Yang G; Lan M; Zhang W
Biomacromolecules; 2019 Dec; 20(12):4563-4573. PubMed ID: 31710484
[TBL] [Abstract][Full Text] [Related]
17. Developing Hypoxia-Sensitive System via Designing Tumor-Targeted Fullerene-Based Photosensitizer for Multimodal Therapy of Deep Tumor.
Li L; Fu J; Ye J; Liu L; Sun Z; Wang H; Tan S; Zhen M; Wang C; Bai C
Adv Mater; 2024 Jun; 36(23):e2310875. PubMed ID: 38450765
[TBL] [Abstract][Full Text] [Related]
18. Dual-action nanoplatform with a synergetic strategy to promote oxygen accumulation for enhanced photodynamic therapy against hypoxic tumors.
Ren C; Xu X; Yan D; Gu M; Zhang J; Zhang H; Han C; Kong L
Acta Biomater; 2022 Jul; 146():465-477. PubMed ID: 35526738
[TBL] [Abstract][Full Text] [Related]
19. Polymer-Upconverting Nanoparticle Hybrid Micelles for Enhanced Synergistic Chemo-Photodynamic Therapy: Effects of Emission-Absorption Spectral Match.
Chen Y; Ren J; Tian D; Li Y; Jiang H; Zhu J
Biomacromolecules; 2019 Oct; 20(10):4044-4052. PubMed ID: 31487160
[TBL] [Abstract][Full Text] [Related]
20. Targeted and Oxygen-Enriched Nanoplatform for Enhanced Photodynamic Therapy: In Vitro 2D Cell and 3D Spheroid Model Evaluation.
Chen CY; Chen CY
Macromol Biosci; 2023 Dec; 23(12):e2300196. PubMed ID: 37565670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
